Professor Garry Taylor was until recently, the Master of the University of St. Andrews, Scotland. A co- inventor of the CBM intellectual property, the ‘Taylor’ lab has a long history in studying the molecular mechanisms of proteins from respiratory pathogens and it is the work of his team that led to the CBM technology and products. Garry is a shareholder, director and advisor to the Company including chairing the Scientific Advisory Board.
This person is not in the org chart
This person is not in any teams